These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vigabatrin-associated reversible acute psychosis in a child. Cánovas Martínez A, Ordovás Baines JP, Beltrán Marqués M, Escrivá Aparisi A, Delgado Cordón F. Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955 [Abstract] [Full Text] [Related]
4. [Acute psychosis and vigabatrin in childhood]. Chiaretti A, Castorina M, Tortorolo L, Piastra M, Polidori G. Pediatr Med Chir; 1994 Nov; 16(5):489-90. PubMed ID: 7885961 [Abstract] [Full Text] [Related]
8. Vigabatrin in epilepsy in mentally retarded patients. Matilainen R, Pitkänen A, Ruutiainen T, Mervaala E, Riekkinen P. Br J Clin Pharmacol; 1989 May 26; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902 [Abstract] [Full Text] [Related]
9. Vigabatrin and behaviour disturbances. Sander JW, Hart YM. Lancet; 1990 Jan 06; 335(8680):57. PubMed ID: 1967367 [No Abstract] [Full Text] [Related]
10. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Trimble MR, Rüsch N, Betts T, Crawford PM. Seizure; 2000 Jun 06; 9(4):249-54. PubMed ID: 10880283 [Abstract] [Full Text] [Related]
11. Vigabatrin: a three year clinical analysis. Martin PJ, Millac PA. Seizure; 1993 Jun 06; 2(2):137-40. PubMed ID: 8167965 [Abstract] [Full Text] [Related]
12. Vigabatrin in the treatment of epilepsy in children. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J. Br J Clin Pharmacol; 1989 Jun 06; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901 [Abstract] [Full Text] [Related]
13. Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. Sander JW, Trevisol-Bittencourt PC, Hart YM, Shorvon SD. J Neurol Neurosurg Psychiatry; 1990 Nov 06; 53(11):1008-10. PubMed ID: 2283513 [Abstract] [Full Text] [Related]
14. Bipolar affective psychosis after vigabatrin. Naumann M, Supprian T, Kornhuber J, Lange KW, Reiners K. Lancet; 1994 Mar 05; 343(8897):606-7. PubMed ID: 7906364 [No Abstract] [Full Text] [Related]
15. Acute encephalopathy with vigabatrin. Sälke-Kellermann A, Baier H, Rambeck B, Boenigk HE, Wolf P. Lancet; 1993 Jul 17; 342(8864):185. PubMed ID: 8101289 [No Abstract] [Full Text] [Related]
16. Pharmacology of vigabatrin. Sabers A, Gram L. Pharmacol Toxicol; 1992 Apr 17; 70(4):237-43. PubMed ID: 1608908 [Abstract] [Full Text] [Related]
17. Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal. Weber P, Dill P, Datta AN. Epilepsy Behav; 2012 May 17; 24(1):138-40. PubMed ID: 22503470 [Abstract] [Full Text] [Related]
18. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Tartara A, Manni R, Galimberti CA, Morini R, Mumford JP, Iudice A, Perucca E. Acta Neurol Scand; 1992 Sep 17; 86(3):247-51. PubMed ID: 1414241 [Abstract] [Full Text] [Related]
19. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. Remy C, Beaumont D. Br J Clin Pharmacol; 1989 Sep 17; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903 [Abstract] [Full Text] [Related]
20. [Alternative Psychoses and Forced Normalization after Seizure Control by Anticonvulsants with Special Consideration of the New Anticonvulsants]. Fröscher W, Steinert T. Fortschr Neurol Psychiatr; 2020 May 17; 88(5):307-317. PubMed ID: 30786318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]